| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, PLASMINOGEN | 0 | 0 | 2 | 2 |
| Chain A, PLASMINOGEN | 0 | 0 | 2 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
| Chain A, Apolipoprotein | 0 | 0 | 1 | 1 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| glucocorticoid receptor [Homo sapiens] | 3 | 0 | 0 | 3 |
| arylsulfatase A | 3 | 0 | 0 | 3 |
| euchromatic histone-lysine N-methyltransferase 2 | 4 | 0 | 0 | 4 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| geminin | 2 | 0 | 0 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Plasminogen | 0 | 4 | 2 | 6 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
| Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 1 | 0 | 0 | 1 |
| Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
| Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
| Glutamate transporter homolog | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 1 | 0 | 0 | 0 | 4 |
| Carbonic anhydrase 2 | 0 | 0 | 0 | 4 |
| N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 3 |
| Excitatory amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Excitatory amino acid transporter 2 | 0 | 1 | 0 | 1 |
| Excitatory amino acid transporter 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 3 |
| Metabotropic glutamate receptor 1 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 3 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 0 | 0 | 2 |
| Plasma kallikrein | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 0 | 0 | 2 |
| Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 6 | 0 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 0 | 1 |
| Adenosine receptor A2a | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 7 | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 2 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| GABA theta subunit | 1 | 0 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 2 |
| Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
| Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
| Luciferase | 1 | 0 | 0 | 1 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| thioredoxin reductase | 1 | 0 | 0 | 1 |
| WRN | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| GLS protein | 1 | 0 | 0 | 1 |
| AR protein | 3 | 0 | 0 | 3 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
| estrogen nuclear receptor alpha | 3 | 0 | 0 | 3 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
| Polyphenol oxidase 2 | 0 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
| USP1 protein, partial | 1 | 0 | 0 | 1 |
| TDP1 protein | 2 | 0 | 0 | 2 |
| GLI family zinc finger 3 | 1 | 0 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
| progesterone receptor | 1 | 0 | 0 | 1 |
| estrogen-related nuclear receptor alpha | 1 | 0 | 0 | 1 |
| G | 1 | 0 | 0 | 1 |
| cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
| aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 1 | 0 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
| Interferon beta | 1 | 0 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
| Cellular tumor antigen p53 | 1 | 0 | 0 | 1 |
| D(2) dopamine receptor | 0 | 3 | 3 | 6 |
| Glutamate receptor 2 | 1 | 0 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 1 | 2 | 3 |
| D(4) dopamine receptor | 0 | 2 | 1 | 3 |
| D(3) dopamine receptor | 0 | 2 | 2 | 5 |
| Spike glycoprotein | 1 | 0 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
| D | 0 | 2 | 0 | 2 |
| cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
| D | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 1 | 2 | 3 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 1E | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Histamine H4 receptor | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 2 | 0 | 0 | 0 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | 1 | 0 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |